Preparation method of (2S, 6R)-6-phenyl-2-piperidine carboxylic acid hydrochloride

Through nucleophilic substitution reaction and subsequent treatment, the problem of difficulty in obtaining raw materials and high cost in the preparation of (2S,6R)-6-phenyl-2-piperidinecarboxylic acid is solved, and a low-cost and efficient preparation method is realized, improving the The purity and reaction rate of the product are obtained.

CN118930476APending Publication Date: 2024-11-12SUZHOU FLEMING BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410987266.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

In the existing preparation methods of (2S,6R)-6-phenyl-2-piperidinecarboxylic acid, raw materials are difficult to obtain, high costs, harsh reaction conditions and low yield, resulting in increased production costs and reduced product purity.

Method used

Using the steps of nucleophilic substitution reaction, decarboxylation reaction, cyclosynthesis reaction and catalytic hydrogenation reduction reaction, intermediates are formed by the first reaction substrate and the second reaction substrate, and further processed under mild conditions, and the reaction is accelerated by potassium iodide. rate, reduce preparation cost.

Benefits of technology

The preparation of (2S,6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride with easy-to-retrieval raw materials and low-cost, improves the reaction rate and product purity, and reduces production costs and energy consumption.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930476A_ABST
    Figure CN118930476A_ABST
Patent Text Reader

Abstract

The invention provides a preparation method of (2S, 6R)-6-phenyl-2-piperidine carboxylic acid hydrochloride, and relates to the technical field of medicine synthesis. The preparation method of the (2S, 6R)-6-phenyl-2-piperidine carboxylic acid hydrochloride comprises the following steps: carrying out nucleophilic substitution reaction on a first reaction substrate and a second reaction substrate to obtain an intermediate; and carrying out a decarboxylation reaction, a cyclization reaction and a catalytic hydrogenation reduction reaction on the intermediate to obtain the (2S, 6R)-6-phenyl-2-piperidine carboxylic acid hydrochloride. L-homoserine and keto ester are subjected to nucleophilic substitution reaction, decarboxylation reaction, cyclization reaction and catalytic hydrogenation reduction reaction to prepare (2S, 6R)-6-phenyl-2-piperidine carboxylic acid hydrochloride, reaction conditions are mild, raw materials are easy to obtain, and the preparation cost is low.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug synthesis, and specifically relates to a preparation method of (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride. Background Art

[0002] (2S,6R)-6-phenyl-2-piperidinecarboxylic acid is an important chiral building block in drug research and synthesis. Therefore, the synthesis of (2S,6R)-6-phenyl-2-piperidinecarboxylic acid plays an extremely important role in the field of drug synthesis and drug research technology.

[0003] In the prior art, in the existing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid synthesis method, a chiral auxiliary group, that is, aminosulfoxide, is usually used to prepare (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid. This preparation method has the problems of difficult to obtain raw materials, high cost, harsh reaction conditions and low safety factor. In other preparation methods of (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid, there are problems such as low yield, poor stereoselectivity, and harsh reaction conditions, which lead to increased production costs and may also affect the purity and quality of the final product. In addition, since the amino group on the (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid ring is easy to react under acidic conditions to generate by-products, the yield and purity of the target product are reduced. By first preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride, the amino group on the (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid ring can be protected.

[0004] Therefore, developing a method for synthesizing (2S,6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride with readily available raw materials and low production cost has important application value. Summary of the invention

[0005] An object of the present invention is to provide a method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride, so as to solve the technical problems in the prior art that chiral piperidinecarboxylic acid raw materials are difficult to obtain and the preparation cost is high.

[0006] Another object of the present invention is to increase the reaction rate of the nucleophilic substitution reaction.

[0007] According to the purpose of the present invention, the present invention provides a method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride, comprising the following steps:

[0008] Using the first reaction substrate and the second reaction substrate to carry out a nucleophilic substitution reaction to obtain an intermediate;

[0009] The intermediate is subjected to a decarboxylation reaction, a cyclization reaction and a catalytic hydrogenation reduction reaction to obtain (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride;

[0010] The general structural formula of the first reaction substrate is:

[0011] The general structural formula of the second reaction substrate is:

[0012] The general structural formula of the intermediate is:

[0013] In this embodiment, Q represents any one of Cl, Br, I, MsO and TsO, and R1, R2 and R3 each independently represent any one of hydrocarbon groups having 1 to 6 carbon atoms.

[0014] Optionally, the step of using the first reaction substrate and the second reaction substrate to perform a nucleophilic substitution reaction to obtain an intermediate further includes the following steps:

[0015] adding an alkaline reagent to the second reaction substrate and mixing them uniformly to prepare a first reaction solution;

[0016] The first reaction substrate is added to the first reaction solution to obtain the intermediate.

[0017] Optionally, the alkaline reagent is sodium hydride or any one of sodium alcoholates or potassium alcoholates such as sodium tert-butoxide and potassium tert-butoxide.

[0018] Optionally, the step of adding an alkaline reagent to the second reaction substrate and mixing them uniformly to prepare the first reaction solution further includes the following steps:

[0019] Potassium iodide is added to the first reaction solution while adding the alkaline agent.

[0020] Optionally, the step of subjecting the intermediate to decarboxylation reaction, cyclization reaction and catalytic hydrogenation reduction reaction to obtain (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride further comprises the following steps:

[0021] The solution containing the intermediate is adjusted to a pH value of a preset acidity, and is sequentially extracted, concentrated, crystallized and filtered to prepare N-oxycarbonyl-6-phenyl-6-oxo-L-hexanine;

[0022] Adding an acidic reagent to the N-oxycarbonyl-6-phenyl-6-oxo-L-hexanine to prepare chiral 2-carboxyl-6-phenyl-cyclopentylimine;

[0023] A catalyst is added to the chiral 2-carboxy-6-phenyl-cyclopentylimine, and (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride is prepared under pressure.

[0024] Optionally, the preset acidity value is any value in the range of 0.8-1.2.

[0025] Optionally, the acidic reagent is a hydrochloric acid solution, and the mass fraction of hydrochloric acid in the hydrochloric acid solution is any value in the range of 20%-40%.

[0026] Optionally, before the step of adjusting the pH of the solution containing the intermediate to a preset acidity value, and sequentially extracting, concentrating, crystallizing and filtering it to prepare N-oxycarbonyl-6-phenyl-6-oxo-L-hexanine, the step further includes:

[0027] Add a NaOH solution with a preset mass fraction and react for a preset time.

[0028] Optionally, the catalyst is palladium carbon, and the mass fraction of palladium in the palladium carbon is any value in the range of 6%-15%.

[0029] Optionally, after the step of adding a catalyst to the chiral 2-carboxy-6-phenyl-cyclopentylimine and preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride under pressure, the following steps are also included:

[0030] The (2S,6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride was filtered, concentrated and recrystallized.

[0031] The invention uses a first reaction substrate and a second reaction substrate to undergo a nucleophilic substitution reaction to obtain an intermediate of (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride, and then performs a decarboxylation reaction, a cyclization reaction and a catalytic hydrogenation reduction reaction on the intermediate to obtain (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride. The reaction conditions are mild, the raw materials are easily available and the cost is low.

[0032] Furthermore, in the preparation method of the present invention, potassium iodide is added to the first reaction substrate to form an iodine-substituted first reaction substrate. The iodine atom in the iodine-substituted first reaction substrate is easily attacked and left by other nucleophilic reagents. This continuous attack and leaving process further accelerates the reaction, thereby increasing the reaction rate of the nucleophilic substitution reaction.

[0033] The above description is only an overview of the technical solution of the present invention. In order to more clearly understand the technical means of the present invention and implement it according to the contents of the specification, the following is a detailed description of the preferred embodiments of the present invention in conjunction with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Hereinafter, some specific embodiments of the present invention will be described in detail in an exemplary and non-limiting manner with reference to the accompanying drawings. The same reference numerals in the accompanying drawings indicate the same or similar components or parts. It should be understood by those skilled in the art that these drawings are not necessarily drawn to scale. In the accompanying drawings:

[0035] Figure 1 is a schematic flow chart of a method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to one embodiment of the present invention;

[0036] Figure 2 is a schematic flow chart of a method for preparing an intermediate according to one embodiment of the present invention;

[0037] Figure 3 The diagram is a schematic partial flow chart of a method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to one embodiment of the present invention. DETAILED DESCRIPTION

[0038] The specific implementation of the present invention is further described in detail below in conjunction with the accompanying drawings and examples. The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.

[0039] In order to make the above-mentioned purposes, features and advantages of the present application more obvious and easy to understand, the specific implementation methods of the present application are described in detail below in conjunction with the accompanying drawings. It is understandable that the specific embodiments described herein are only used to explain the present application, rather than to limit the present application. It should also be noted that, for ease of description, only some structures related to the present application are shown in the accompanying drawings, rather than all structures. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of this application.

[0040] The terms "including" and "having" and any variations thereof in this application are intended to cover non-exclusive inclusions. For example, a process, method, system, product or device comprising a series of steps or units is not limited to the listed steps or units, but may optionally include steps or units not listed, or may optionally include other steps or units inherent to these processes, methods, products or devices.

[0041] Reference to "embodiments" herein means that a particular feature, structure, or characteristic described in conjunction with the embodiments may be included in at least one embodiment of the present application. The appearance of the phrase in various locations in the specification does not necessarily refer to the same embodiment, nor is it an independent or alternative embodiment that is mutually exclusive with other embodiments. It is explicitly and implicitly understood by those skilled in the art that the embodiments described herein may be combined with other embodiments.

[0042] Figure 1 The figure is a schematic flow chart of a method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to one embodiment of the present invention.

[0043] like Figure 1 As shown, the present invention provides a method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride, comprising the following steps:

[0044] Step S100: using the first reaction substrate and the second reaction substrate to perform a nucleophilic substitution reaction to obtain an intermediate.

[0045] Step S200: subjecting the intermediate to decarboxylation reaction, cyclization reaction and catalytic hydrogenation reduction reaction to obtain (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride.

[0046] The general structural formula of the first reaction substrate is:

[0047] The general structural formula of the second reaction substrate is:

[0048] The general structural formula of the intermediate is:

[0049] Wherein, Q represents any one of Cl, Br, I, MsO and TsO, and R1, R2 and R3 each independently represent any one of hydrocarbon groups having 1 to 6 carbon atoms.

[0050] In step S100 and step S200, the general reaction formula of the preparation method of (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride is:

[0051]

[0052] In the present embodiment, the first reaction substrate is an L-homoserine derivative, and the terminal hydroxyl group of the first reaction substrate is replaced by any active group of Cl, Br, I, MsO and TsO, the second reaction substrate is a ketoester derivative, and the second reaction substrate contains an active methine, the first reaction substrate and the second reaction substrate undergo a nucleophilic substitution reaction, that is, the end of the first reaction substrate replaced by the active group undergoes a nucleophilic substitution reaction at the active methine of the second reaction substrate to obtain an intermediate of (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride, and then the intermediate is subjected to a decarboxylation reaction, a cyclization reaction and a catalytic hydrogenation reduction reaction to obtain (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride. In the present embodiment, the reaction conditions for preparing the intermediate by using an L-homoserine derivative and a ketoester to undergo a nucleophilic substitution reaction are mild, and the raw materials are readily available and the cost is low.

[0053] In this embodiment, the terminal group of the first reaction substrate can be any active group of Cl, Br, I, MsO and TsO. In the nucleophilic substitution reaction, the active group has strong leaving ability, fast reaction rate and high product stability. The leaving of the active group makes the terminal carbon atom of the first reaction substrate positively charged, which can accelerate the reaction rate of the nucleophilic substitution reaction between the first reaction substrate and the second reaction substrate, and improve the preparation reaction rate of the intermediate. Here, the active group can be selected according to the reaction conditions and the requirements of the target product, and is not specifically limited here.

[0054] In a preferred embodiment, the active group is TsO. Since the sulfonyl group has a large volume and a high charge density, the CS bond is relatively weak and easy to break. That is, TsO has a strong leaving ability. After replacing the terminal hydroxyl group of the first reaction substrate as an active group, the first reaction substrate is more likely to form a nucleophilic molecule, thereby increasing the reaction rate of the nucleophilic substitution reaction between the first reaction substrate and the second reaction substrate.

[0055] In this embodiment, R1, R2, and R3 each independently represent any one of the hydrocarbon groups with carbon atoms of 1-6, that is, R1 can be any one of the hydrocarbon groups with carbon atoms of 1, 2, 3, 4, 5, or 6, R2 can be any one of the hydrocarbon groups with carbon atoms of 1, 2, 3, 4, 5, or 6, and R3 can be any one of the hydrocarbon groups with carbon atoms of 1, 2, 3, 4, 5, or 6. Since the nucleophilic substitution reaction, decarboxylation reaction, cyclization reaction, and catalytic hydrogenation reaction all need to react in a solution, when R1, R2, and R3 represent carbon atoms of 1-6, the formed ester compound usually has good solubility and can be dissolved in a variety of organic solvents, which is conducive to the smooth progress of the nucleophilic substitution reaction, decarboxylation reaction, cyclization reaction, and catalytic hydrogenation reaction.

[0056] In a preferred embodiment, R2 is a tert-butyl group to form a tert-butyloxycarbonyl group, and the formed tert-butyloxycarbonyl group replaces a hydrogen atom of the amino group to form a protecting group of the amino group, thereby preventing the amino group from acting as a nucleophilic reagent and reacting with the halogenated hydrocarbon to affect the nucleophilic substitution reaction. In addition, by using the tert-butyloxycarbonyl group to protect the amino group, other groups are more easily selected and modified in subsequent reactions, thereby improving the selectivity of the reaction and the purity of the product. In addition, since the tert-butyloxycarbonyl group can exist stably under specific conditions, it can also be removed by acid-catalyzed hydrolysis and hydrogenation reduction reactions, thereby achieving precise control of the reaction process.

[0057] In one embodiment, when R1 is methyl, R2 is tert-butyl, R3 is methyl, Q is MsO, the first reaction substrate is (S)-N-tert-butoxycarbonyl-O-methylsulfonyl-L-homoserine methyl ester, the second reaction substrate is 3-phenyl-3-oxopropionic acid methyl ester, and the intermediate is (S)-N-tert-butoxycarbonyl-6-phenyl-6-oxo-L-hexanine.

[0058] In the present embodiment, the first reaction substrate is an L-homoserine derivative, first by using pyruvic acid and formaldehyde to react, then using transaminase catalysis to obtain L-homoserine, or by selectively hydrolyzing L-aspartic acid diester, and then using borohydride reduction to obtain L-homoserine. Then L-homoserine is reacted with active groups under alkaline conditions to generate L-homoserine derivatives. The reaction raw materials in the present embodiment are easy to obtain and have low cost, so as to reduce the preparation cost of L-homoserine derivatives, thereby reducing the preparation cost of (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride.

[0059] In this embodiment, the second reaction substrate is a ketoester derivative, which is generated by a nucleophilic substitution reaction between acetophenone and a carbonic acid diester compound under alkaline conditions. The reaction conditions are mild and the raw materials are readily available, so as to reduce the preparation cost of the second reaction substrate, thereby reducing the preparation cost of (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride.

[0060] Figure 2 is a schematic flow chart of a method for preparing an intermediate according to one embodiment of the present invention.

[0061] like Figure 2 As shown, in a further embodiment, in step S100, the following steps are also included:

[0062] Step S110: adding an alkaline reagent to the second reaction substrate and mixing them evenly to prepare a first reaction solution.

[0063] Step S120: adding the first reaction substrate to the first reaction solution to obtain an intermediate.

[0064] In the present embodiment, first an alkaline reagent is added in the second reaction substrate, to form a carbanion in the methine of the second reaction substrate, i.e., the second reaction substrate forms a nucleophilic molecule, and after the end active group Q of the first reaction substrate leaves, a nucleophilic substitution reaction occurs between the end carbon atom of the nucleophilic molecule and the first reaction substrate, to prepare an intermediate. In other words, the nucleophilic molecule attacks from the back side of the first reaction substrate, so that the obtained intermediate undergoes configuration inversion, for the convenience of subsequent (2S, 6R) -6- phenyl -2- piperidinecarboxylic acid hydrochloride synthesis. The present embodiment obtains the reaction conditions of the intermediate to be gentle, the reaction rate is fast and the yield is high, and the preparation cost of (2S, 6R) -6- phenyl -2- piperidinecarboxylic acid hydrochloride can be significantly reduced, so as to reduce energy consumption and environmental pollution.

[0065] In step S110, the second reaction substrate first needs to be dissolved in an aprotic solvent, and the aprotic solvent is any one of tetrahydrofuran, dimethylformamide, dimethyl sulfoxide, toluene, or a mixed solvent comprising one or more of the above reagents. Since the aprotic solvent easily solvates the cations and does not affect the anions, the anions of the methine in the second reaction substrate are exposed, that is, the anions of the nucleophilic reagent are exposed, which is conducive to the nucleophilic reagent attacking the electron-deficient first reaction substrate, thereby accelerating the reaction rate of the nucleophilic substitution reaction.

[0066] In step S100, an alkaline reagent is added to the second reaction substrate, mixed evenly and reacted for a preset time at room temperature to prepare a first reaction solution, and the preset time is any value in the range of 0.8-1.2h. That is, the reaction time of the second reaction substrate and the alkaline reagent can be 0.8h, 0.9h, 1.0h, 1.1h or 1.2h, or any other value in 0.8-1.2h, so that the alkaline reagent reacts fully with the second reaction substrate to prepare a second reaction substrate containing a carbon anion. When the preset time is less than 0.8h, the alkaline reagent does not react sufficiently with the second reaction substrate, resulting in the carbon anion of the second reaction substrate not being fully exposed, thereby affecting the reaction rate and product yield of the nucleophilic substitution reaction. When the preset time is greater than 1.2h, the reaction time of the intermediate will increase, resulting in an increase in the time cost of (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride.

[0067] In step S120, the first reaction substrate is first dissolved in an aprotic solvent. After the first reaction substrate is added to the first reaction solution, a reflux reaction is performed under a first preset temperature condition. The first preset temperature is any value in the range of 45°C-55°C. The reaction time of the reflux reaction is any value in the range of 5h-7h, that is, the reaction time of the nucleophilic substitution reaction is any value in the range of 5h-7h. That is, the first preset temperature of the nucleophilic substitution reaction can be 45°C, 46°C, 47°C, 48°C, 50°C, 52°C, 54°C or 55°C, or any other value in the range of 45°C-55°C, and the reaction time of the nucleophilic substitution reaction can be 5h, 5.5h, 6h, 6.5h or 7h, or any other value in the range of 5h-7h. The first preset temperature is any value between 45°C and 55°C, and the reaction time is any value between 5h and 7h, which helps to avoid the occurrence of side reactions in the nucleophilic substitution reaction, while maintaining the activity of the first reaction substrate and the second reaction substrate, and improving the product yield and product purity of the intermediate. When the first preset temperature is lower than 45°C, the rate of the nucleophilic substitution reaction will be reduced, and when the first preset temperature is higher than 55°C, the activity of the first reaction substrate and the second reaction substrate will be reduced, thereby reducing the reaction rate of the nucleophilic substitution reaction.

[0068] In a further embodiment, alkaline reagent is any one of sodium alkoxide or sodium tert-butoxide, potassium tert-butoxide and the like sodium alkoxide or potassium alkoxide.In the present embodiment, sodium alkoxide or sodium alkoxide or potassium alkoxide and the like sodium alkoxide or potassium alkoxide have strong alkalinity, can effectively deprotonate the acidic hydrogen atom in the second reaction substrate, generate corresponding anion intermediate, thus enhance the nucleophilicity and reactivity of nucleophilic reagent, make nucleophilic substitution reaction easier to carry out, improve reaction rate and efficiency.Meanwhile, in nucleophilic substitution reaction, strong alkaline reagent can accelerate the back attack of nucleophilic reagent to leaving group, is conducive to forming new chemical bond, avoids configuration inversion and configuration maintenance simultaneously and causes the problem of racemic body generation, avoids the generation of by-product.

[0069] In the present embodiment, the ratio of the amount of substance of the alkaline reagent to the second reaction substrate is any value in 1-1.5. That is, the ratio of the amount of substance of the alkaline reagent to the second reaction substrate can be 1.1, 1.2, 1.3, 1.4 or 1.5, or any other value in 1-1.5. In other words, when the amount of substance of the alkaline reagent is the same as that of the second reaction substrate, or when the amount of substance of the alkaline reagent is greater than that of the second reaction substrate, the alkaline reagent can ensure the smooth progress of the nucleophilic substitution reaction while reducing unnecessary side reactions, such as base-catalyzed hydrolysis reaction and elimination reaction. At the same time, when the ratio of the amount of substance of the alkaline reagent to the second reaction substrate is any value in 1-1.5, the product yield and product purity of the intermediate can also be improved.

[0070] In a further embodiment, the step of adding an alkaline reagent to the second reaction substrate and mixing uniformly to prepare the first reaction solution further includes the following steps:

[0071] Potassium iodide is added to the first reaction solution simultaneously with the addition of the alkaline agent.

[0072] In the present embodiment, the iodide ion in potassium iodide is a nucleophilic reagent, which can attack and replace any active group in Cl, Br, I, MsO and TsO represented by Q in the first reaction substrate, forming iodine to replace the first reaction substrate, and iodine replaces the iodine atom in the first reaction substrate and is easily attacked and left by other nucleophilic reagents, and this continuous attack and leaving process further accelerate the reaction. In addition, the addition of potassium iodide can promote the activation of the first reaction substrate, making it more susceptible to the attack of nucleophilic reagents, thereby improving the reaction rate of nucleophilic substitution reaction. Meanwhile, potassium iodide can also be used as a catalyst for nucleophilic substitution reaction, accelerating the reaction rate by reducing the activation energy of the reaction.

[0073] After step S120, the following steps are also included:

[0074] S130: performing atmospheric distillation on the solution containing the intermediate to recover the aprotic solvent;

[0075] S140: When the temperature of the solution containing the intermediate reaches a second preset temperature, the recovery of the aprotic solvent is stopped, and the solution containing the intermediate is cooled to room temperature.

[0076] In step S130, the solution containing the intermediate is distilled at atmospheric pressure to recover the aprotic solvent, so that the recovered aprotic solvent can be continuously used in subsequent steps to save costs. In addition, the recovery of the aprotic solvent can reduce the amount of other reagents required for subsequent extraction, concentration, etc. to remove the aprotic solvent, reduce energy waste, and reduce preparation costs.

[0077] In step S140, when the temperature of the solution containing the intermediate rises to the second preset temperature, the recovery of the aprotic solvent is stopped, and the solution containing the intermediate is cooled to room temperature to facilitate the subsequent decarboxylation reaction and cyclization reaction. Here, the second preset temperature is any value in the range of 70°C-85°C, that is, the second preset temperature can be 70°C, 72°C, 74°C, 76°C, 78°C, 80°C, 82°C or 85°C, or any value in 70°C-85°C. When the second preset temperature is within the above temperature range, it can ensure that the aprotic solvent is fully recovered while avoiding the generation of by-products caused by excessively high temperatures. The second preset temperature above 85°C will cause the volatilization of aprotic solvents and intermediates, resulting in waste of resources and increased preparation costs. The second preset temperature is lower than 75°C, which will reduce the recovery efficiency of aprotic solvents and waste energy.

[0078] Figure 3 The diagram is a schematic partial flow chart of a method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to one embodiment of the present invention.

[0079] like Figure 3 As shown, in a further embodiment, in step S200, the following steps are also included:

[0080] Step S210: adjusting the pH of the solution containing the intermediate to a preset acidity value, and sequentially extracting, concentrating, crystallizing and filtering the solution to prepare N-oxycarbonyl-6-phenyl-6-oxo L-hexanine.

[0081] Step S220: adding an acidic reagent to N-oxycarbonyl-6-phenyl-6-oxo-L-hexanine to prepare chiral 2-carboxyl-6-phenyl-cyclopentylimine.

[0082] Step S230: adding a catalyst to chiral 2-carboxy-6-phenyl-cyclopentylimine, and preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride under pressure.

[0083] In the present embodiment, the solution containing the intermediate is first adjusted to an acidic condition to perform a decarboxylation reaction, and then an acidic reagent is added so that the above solution continues to remain in an acidic condition to perform a cyclization reaction, and finally a catalyst is added and a catalytic hydrogenation reduction reaction is performed under pressure to prepare (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride. The reaction conditions of the decarboxylation reaction, cyclization reaction, and catalytic hydrogenation reaction in the present embodiment are mild and simple to operate, so that the preparation cost of preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride is reduced.

[0084] In step S210, the pH of the solution containing the intermediate is adjusted using a hydrochloric acid solution, and the mass fraction of the hydrochloric acid solution is any value in the range of 10%-15%. That is, the mass fraction of the hydrochloric acid solution can be 10%, 11%, 12%, 13%, 14% or 15%, or any other value in the range of 10%-15%. The hydrochloric acid solution with a mass fraction of 10%-15% can adjust the pH of the solution containing the intermediate without destroying the stability of the intermediate, while avoiding the occurrence of safety problems caused by excessively high mass fractions of hydrochloric acid.

[0085] In step S210, toluene is added to the obtained solution containing the intermediate, and layered extraction is performed, and the organic layer obtained by the layered extraction is washed with water for multiple times to remove other reagents in the solution containing the intermediate, and the obtained organic layer is concentrated, and an isopropanol solution is added to the residue produced by the concentration, and a solid product N-oxycarbonyl-6-phenyl-6-oxo L-hexanine is obtained through crystallization, cooling filtration and drying. By extracting, washing, concentrating, crystallizing, filtering and drying the solution containing the intermediate, N-oxycarbonyl-6-phenyl-6-oxo L-hexanine is finally obtained to improve the yield and product purity of N-oxycarbonyl-6-phenyl-6-oxo L-hexanine.

[0086] In step S220, an acidic reagent is added to N-oxycarbonyl-6-phenyl-6-oxo L-hexanine to perform a ring-closure reaction to prepare chiral 2-carboxyl-6-phenyl-cyclopentyl imine. The reaction time of the ring-closure reaction is any value in the range of 7h-9h, that is, the reaction time of the ring-closure reaction can be 7.5h, 8h, 8.5h or 9h, or any value in 7h-9h. The reaction time of the ring-closure reaction exceeds 9h, which will cause more by-products to be produced, and increase the time cost of the overall reaction. The reaction time of the ring-closure reaction is shorter than 7.5h, which will cause the ring-closure reaction to be incomplete, affecting the yield and product purity of chiral 2-carboxyl-6-phenyl-cyclopentyl imine.

[0087] In step S230, a catalyst is added to the chiral 2-carboxyl-6-phenyl-cyclopentyl imine, and a catalytic hydrogenation reduction reaction is performed under pressure to prepare (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride. In this embodiment, the reaction temperature of the catalytic hydrogenation reduction reaction is any value in the range of 45°C-55°C, the reaction time is any value in the range of 5h-7h, the pressurization condition is hydrogen pressurization, and the pressure value of the hydrogen is in the range of 1kg / cm 2 -5kg / cm 2 That is, the reaction temperature of the catalytic hydrogenation reduction reaction can be 45°C, 47°C, 49°C, 50°C, 52°C, 54°C or 55°C, or any other value between 45°C and 55°C; the reaction time can be 5h, 5.5h, 6h, 6.5h or 7h, or any other value between 5h and 7h; the pressurization condition is hydrogen pressurization, and the pressure value of the hydrogen can be 1kg / cm 2 , 2kg / cm 2 , 3kg / cm 2 , 4kg / cm 2 or 5kg / cm 2 , or 1kg / cm 2 -5kg / cm 2Any other value in can increase the reaction rate of the catalytic hydrogenation reaction, reduce the time cost of the overall reaction, and at the same time improve the yield and product purity of (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride.

[0088] In a further embodiment, the preset acidity value is any value in the range of 0.8-1.2. That is, the preset acidity value can be 0.8, 0.85, 0.9, 0.95, 1.0, 1.05, 1.1 or 1.2, or any other value in the range of 0.8-1.2. In other words, the pH of the solution containing the intermediate for decarboxylation reaction is within the range of 0.8-1.2, which can ensure the normal progress of the decarboxylation reaction while avoiding the reaction rate of the decarboxylation reaction being reduced due to the excessive or low pH of the solution.

[0089] In a further embodiment, the acidic reagent is a hydrochloric acid solution, and the mass fraction of hydrochloric acid in the hydrochloric acid solution is any value in the range of 20%-40%. That is, the mass fraction of hydrochloric acid in the hydrochloric acid solution can be 20%, 22%, 25%, 27%, 29%, 30%, 32%, 35%, 37% or 40%, or any other value in the range of 20%-40%. In other words, using a hydrochloric acid solution with a mass fraction of 20%-40% to adjust the acidic conditions required for the cyclization reaction can ensure that the reactants and products of the cyclization reaction are not destroyed while ensuring the acidic conditions required for the cyclization reaction.

[0090] In a further embodiment, the solution containing the intermediate is adjusted to a pH value of a preset acidity, and is sequentially extracted, concentrated, crystallized and filtered to prepare N-oxycarbonyl-6-phenyl-6-oxo-L-hexanine, and the following steps are also included before the step of:

[0091] Add a NaOH solution with a preset mass fraction and react for a preset time.

[0092] In the present embodiment, the intermediate is mixed evenly with a NaOH solution of a preset mass fraction to perform a hydrolysis reaction of the ester group and generate sodium carboxylate, which is convenient for subsequent decarboxylation reaction under acidic conditions. Wherein, the reaction time of the hydrolysis reaction is any value in the range of 1.5h-2.5h. That is, the reaction time of the hydrolysis reaction can be 1.5h, 1.7h, 1.9h, 2.0h, 2.2h, 2.4h or 2.5h, or any other value in 1.5h-2.5h. When the reaction time of the hydrolysis reaction is within the range of 1.5h-2.5h, it is possible to ensure that the hydrolysis reaction of the ester group in the intermediate is completely carried out, and avoid incomplete hydrolysis reaction due to too short a reaction time, or increased overall reaction time cost due to too long a reaction time.

[0093] In a further embodiment, the catalyst is palladium carbon, and the mass fraction of palladium in palladium carbon is any value in the range of 6%-15%. That is, the mass fraction of palladium in palladium carbon can be 6%, 7%, 8%, 9%, 12%, 13% or 15%, or any other value in 6%-15%. Palladium carbon has high activity and high selectivity, and can catalyze the hydrogenation reduction reaction under mild conditions, reducing energy consumption and the generation of by-products. At the same time, palladium carbon has good stability and can maintain its catalytic activity for a long time. In addition, palladium carbon, as a catalyst, can be recovered and purified by treatment after the reaction, and reused after reprocessing, thereby reducing production costs and reducing the impact on the environment.

[0094] In a preferred embodiment, the mass fraction of palladium in palladium carbon is 10%, which can improve the catalytic hydrogenation reduction reaction while avoiding waste of resources due to excessive mass fraction of palladium in palladium carbon.

[0095] In a further embodiment, after step S230, the following steps are further included:

[0096] (2S,6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride was filtered, concentrated and recrystallized.

[0097] In the present embodiment, by filtering, concentrating and recrystallizing the prepared (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride, the solid impurities in the reaction mixture can be removed by filtration, the catalyst palladium carbon can be recovered while the purity of the product is improved, and the concentration can reduce the volume of the solution, increase the concentration of the solute, effectively reduce the amount of solvent used in the subsequent recrystallization, reduce energy consumption, and reduce costs. In the process of recrystallization, the solute is recrystallized from the solution through steps such as dissolving, cooling crystallization, and filtering, thereby improving the purity of (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride.

[0098] In one embodiment, R1 is methyl, R2 is tert-butyl, R3 is methyl, the first reaction substrate is 2-tert-butoxycarbonylamino-4-chlorobutyric acid ethyl ester, and the second reaction substrate is 3-phenyl-3-oxopropionic acid methyl ester. The first reaction substrate and the second reaction substrate undergo a nucleophilic substitution reaction in the presence of NaH to prepare N-tert-butoxycarbonyl-6-phenyl-6-oxo L-hexanine.

[0099] In another embodiment, R1 is methyl, R2 is tert-butyl, R3 is methyl, the first reaction substrate is N-tert-butoxycarbonyl-O-methylsulfonyl-L-homoserine methyl ester, and the second reaction substrate is 3-phenyl-3-oxopropionic acid methyl ester. The first reaction substrate and the second reaction substrate undergo a nucleophilic substitution reaction in the presence of sodium alkoxide to prepare N-tert-butoxycarbonyl-6-phenyl-6-oxoL-hexanine.

[0100] In one embodiment, a solvent is directly added to the prepared N-tert-butoxycarbonyl-6-phenyl-6-oxo-L-hexanine to obtain an N-tert-butoxycarbonyl-6-phenyl-6-oxo-L-hexanine solution. After the N-tert-butoxycarbonyl-6-phenyl-6-oxo-L-hexanine is completely dissolved, the solution is transferred to a reaction bottle to perform subsequent cyclization reaction and catalytic hydrogenation reduction reaction.

[0101] The compound composition and mass fraction of the amorphous composition in the present application will be further described in detail below in conjunction with specific examples, and the preparation and optical properties of the holographic polymer dispersed amorphous composition grating prepared based on the amorphous composition will be further described in detail.

[0102] Example 1

[0103] Add 56mmol 3-phenyl-3-oxopropionic acid methyl ester, 30mL tetrahydrofuran, and 30mL toluene to the reaction bottle, and stir the reaction at room temperature for 1h after adding 59mmol sodium hydride, then add 1gKI, mix well to prepare the first reaction solution. Add 50mmol 2-tert-butoxycarbonylamino-4-chlorobutyric acid ethyl ester toluene solution to the first reaction solution, react at 50°C for 6h to perform nucleophilic substitution reaction to obtain a solution containing an intermediate. Add 25g10% NaOH dropwise to the solution containing the intermediate, react at room temperature for 2h, then adjust the pH of the above solution to 1 to perform a decarboxylation reaction, then perform layered extraction, wash the organic layer with water, concentrate the organic layer, crystallize and filter, and finally dry to obtain a solid product N-tert-butoxycarbonyl-6-phenyl-6-oxo L-hexanine.

[0104] Add 10mmol N-tert-butyloxycarbonyl-6-phenyl-6-oxo-L-hexanine, 10mL glacial acetic acid and 20mL 30% hydrochloric acid to the reaction bottle, mix well and reflux reaction. After 8 hours, concentrate under reduced pressure to precipitate solid product chiral 2-carboxyl-6-phenyl-cyclopentyl imine. Add 30mL methanol solution to dissolve the solid product, and add 0.8g 10% palladium carbon. 2 After the reaction is completed, the reaction solution is filtered, concentrated and recrystallized to obtain (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride.

[0105] Example 2

[0106] The only difference between Example 2 and Example 1 is that 100 mL of methanol solution is directly added to the prepared N-tert-butoxycarbonyl-6-phenyl-6-oxo-L-hexanine, and after the N-tert-butoxycarbonyl-6-phenyl-6-oxo-L-hexanine is completely dissolved, the N-tert-butoxycarbonyl-6-phenyl-6-oxo-L-hexanine solution is obtained, and the above solution is transferred to a reaction bottle for subsequent cyclization reaction and catalytic hydrogenation reduction reaction.

[0107] Example 3

[0108] Add 56mmol 3-phenyl-3-oxopropionic acid methyl ester and 60mL toluene to the reaction bottle, mix well, add 56mmol sodium methoxide and 1gKI, stir and react for 1h at room temperature to prepare the first reaction solution. Add 50mmol N-tert-butyloxycarbonyl-O-methylsulfonyl-L-homoserine methyl ester dropwise to the first reaction solution, react at 70°C for 6h to perform a nucleophilic substitution reaction to obtain a solution containing an intermediate. The solution containing the intermediate is cooled to room temperature, 25g 10% NaOH is added dropwise, and reacted at room temperature for 2h, after which the pH of the above solution is adjusted to 1 to perform a decarboxylation reaction, and then the obtained solution is subjected to layered extraction, organic layer washing, organic layer concentration, crystallization and filtration, and finally dried to obtain a solid product N-tert-butyloxycarbonyl-6-phenyl-6-oxo L-hexane.

[0109] Add 10mmol N-tert-butyloxycarbonyl-6-phenyl-6-oxo-L-hexanine, 10mL glacial acetic acid and 20mL 30% hydrochloric acid to the reaction bottle, mix well and reflux reaction, after 8 hours, concentrate under reduced pressure to precipitate solid product chiral 2-carboxyl-6-phenyl-cyclopentyl imine. Add 30mL methanol solution to dissolve the above solid product, and add 0.8g 10% palladium carbon, and carry out catalytic hydrogenation reduction reaction at a temperature of 50°C and a hydrogen pressure of 3kg / cm2. After the reaction is completed, filter, concentrate and recrystallize the reaction solution to obtain (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride.

[0110] Example 4

[0111] The only difference between Example 4 and Example 3 is that 100 mL of methanol solution is directly added to the prepared N-tert-butoxycarbonyl-6-phenyl-6-oxo-L-hexanine, and after the N-tert-butoxycarbonyl-6-phenyl-6-oxo-L-hexanine is completely dissolved, the N-tert-butoxycarbonyl-6-phenyl-6-oxo-L-hexanine solution is obtained, and the above solution is transferred to a reaction bottle for subsequent cyclization reaction and catalytic hydrogenation reduction reaction.

[0112] The products prepared in Examples 1-4 were further analyzed to obtain the results shown in Table 1.

[0113] Table 1. Yield and purity of intermediates

[0114] Mass / g Yield HPLC ee% Example 1 12.5 78% 98% 99% Example 3 13.0 81% 98% 99%

[0115] Table 2. Yield and purity of (2S,6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride

[0116]

[0117] As shown in Tables 1 and 2, the product HPLC of (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride reached 98%, and the yield reached 65% or more, indicating that the product purity and yield of the (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride prepared in Examples 1-4 were both high, and the ee% reached 99%, that is, the enantiomeric excess reached 99%, indicating that the enantiomeric content in Examples 1-4 was high, that is, the purity of the prepared (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride was high.

[0118] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0119] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.

Claims

1. A method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride, characterized in that: The steps include: Using the first reaction substrate and the second reaction substrate to carry out a nucleophilic substitution reaction to obtain an intermediate; The intermediate is subjected to a decarboxylation reaction, a cyclization reaction and a catalytic hydrogenation reduction reaction to obtain (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride; The general structural formula of the first reaction substrate is: The general structural formula of the second reaction substrate is: The general structural formula of the intermediate is: Wherein, Q represents any one of Cl, Br, I, MsO and TsO, and R1, R2 and R3 each independently represent any one of hydrocarbon groups having 1 to 6 carbon atoms.

2. The method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to claim 1, characterized in that: The step of using the first reaction substrate and the second reaction substrate to perform a nucleophilic substitution reaction to obtain an intermediate further includes the following steps: adding an alkaline reagent to the second reaction substrate and mixing them uniformly to prepare a first reaction solution; The first reaction substrate is added to the first reaction solution to obtain the intermediate.

3. The method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to claim 2, characterized in that: The alkaline reagent is any one of sodium hydride or sodium tert-butoxide, potassium tert-butoxide and other sodium or potassium alcoholates.

4. The method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to claim 3, characterized in that: The step of adding an alkaline reagent to the second reaction substrate and mixing them uniformly to prepare a first reaction solution further includes the following steps: Potassium iodide is added to the first reaction solution while adding the alkaline agent.

5. The method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to claim 4, characterized in that: The step of subjecting the intermediate to decarboxylation reaction, cyclization reaction and catalytic hydrogenation reduction reaction to obtain (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride further includes the following steps: The solution containing the intermediate is adjusted to a pH value of a preset acidity, and is sequentially extracted, concentrated, crystallized and filtered to prepare N-oxycarbonyl-6-phenyl-6-oxo-L-hexanine; Adding an acidic reagent to the N-oxycarbonyl-6-phenyl-6-oxo-L-hexanine to prepare chiral 2-carboxyl-6-phenyl-cyclopentylimine; A catalyst is added to the chiral 2-carboxy-6-phenyl-cyclopentylimine, and (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride is prepared under pressure.

6. The method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to claim 5, characterized in that: The preset acidity value is any value in the range of 0.8-1.

2.

7. The method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to claim 6, characterized in that: The acidic reagent is a hydrochloric acid solution, and the mass fraction of hydrochloric acid in the hydrochloric acid solution is any value in the range of 20%-40%.

8. The method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to claim 7, characterized in that: Before the step of adjusting the pH of the solution containing the intermediate to a preset acidity value, and sequentially extracting, concentrating, crystallizing and filtering it to prepare N-oxycarbonyl-6-phenyl-6-oxo-L-hexanine, the step further includes the following steps: Add a NaOH solution with a preset mass fraction and react for a preset time.

9. A method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to any one of claims 5 to 8, characterized in that: The catalyst is palladium carbon, and the mass fraction of palladium in the palladium carbon is any value in the range of 6%-15%.

10. The method for preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride according to claim 9, characterized in that: After the step of adding a catalyst to the chiral 2-carboxyl-6-phenyl-cyclopentylimine and preparing (2S, 6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride under pressure, the following steps are also included: The (2S,6R)-6-phenyl-2-piperidinecarboxylic acid hydrochloride was filtered, concentrated and recrystallized.